The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Abstract
In most cases symptoms of autism begin in early infancy. However, a subset of children appears to develop normally until a clear deterioration is observed. Many parents of children with "regressive"-onset autism have noted antecedent antibiotic exposure followed by chronic diarrhea. We speculated that, in a subgroup of children, disruption of indigenous gut flora might promote colonization by one or more neurotoxin-producing bacteria, contributing, at least in part, to their autistic symptomatology. To help test this hypothesis, 11 children with regressive-onset autism were recruited for an intervention trial using a minimally absorbed oral antibiotic. Entry criteria included antecedent broad-spectrum antimicrobial exposure followed by chronic persistent diarrhea, deterioration of previously acquired skills, and then autistic features. Short-term improvement was noted using multiple pre- and post-therapy evaluations. These included coded, paired videotapes scored by a clinical psychologist blinded to treatment status; these noted improvement in 8 of 10 children studied. Unfortunately, these gains had largely waned at follow-up. Although the protocol used is not suggested as useful therapy, these results indicate that a possible gut flora-brain connection warrants further investigation, as it might lead to greater pathophysiologic insight and meaningful prevention or treatment in a subset of children with autism. (J Child Neurol 2000;15:429-435).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“antibiotic treatment may also improve symptoms in idiopathic forms of ASD239–241”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [240]
In the citing paper
“Interestingly, a small clinical study of vancomycin treatment in ASD children reported some improvements in ASD behaviors, which waned when antibiotic treatment was discontinued (50), suggesting that the microbiome may contribute actively to the severity of behavioral abnormalities in ASD.”
From Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder (2017) · cites this paper as [50]
In the citing paper
“A small pilot study included 11 children with a regressive form of ASD and who had GI symptoms of diarrhea that were treated with oral vancomycin for 8 weeks, followed by 4 weeks of probiotics. Eight of these children (~73%) experienced significantly improved impairments in social behavior and communication.”
From The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders (2018) · cites this paper as [46]
In the citing paper
“However, these improvements did not endure, with most children reverting to their starting behavioral impairments upon removal of the treatment [46].”
From The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders (2018) · cites this paper as [46]
In the citing paper
“microbial-based interventions, including fecal transplantation, antibiotics, and probiotics, have shown promise in a limited number of human trials (Grimaldi et al., 2018; Kang et al., 2017b; Sandler et al., 2000).”
From Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice (2019) · cites this paper as Sandler et al., 2000
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
(1943) · The Nervous child · Cited by 8,870
Wadsworth anaerobic bacteriology manual
Sutter, V. L., Citron, D. M., & Finegold, S. M. (1980) · Medical Entomology and Zoology · Cited by 1,388
Self-citationColonization resistance of the digestive tract in conventional and antibiotic-treated mice
Van der Waaij, D., Berghuis-de Vries, J. M., & Lekkerkerk-van der Wees, J. E. C. (1971) · Journal of Hygiene · doi:10.1017/s0022172400021653 · Cited by 901
Normal Indigenous Intestinal Flora
FINEGOLD, S. M., SUTTER, V. L., & MATHISEN, G. E. (1983) · Human Intestinal Microflora in Health and Disease · doi:10.1016/b978-0-12-341280-5.50007-0 · Cited by 616
Self-citationMechanism of action of tetanus and botulinum neurotoxins
Montecucco, C., & Schiavo, G. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00396.x · Cited by 551
Botulism in the United States: A Clinical and Epidemiologic Review
Shapiro, R. L., Hatheway, C., & Swerdlow, D. L. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-3-199808010-00011 · Cited by 508
Autistic children: infancy to adulthood.
Rutter, M. L. (1970) · PubMed · Cited by 507
Tuchman, R. F., & Rapin, I. (1997) · Pediatrics · doi:10.1542/peds.99.4.560 · Cited by 470
Research works printed but not linked: 5
- Kanner L., 1943, Nerv Child, 2, 217
- Rutter M., 1970, Semin Psychiatry, 2, 435
- Alpern G., 1995, Los Angeles, Western Psychological Services,
- Schopler E., 1995, The Autism Rating Scale Manual
- Conway P.: Microbial ecology of the human large intestine, in Gibson G, Macfarlane G (eds): Human Colonic Bacteria—Role in Nutrition, Physiology, and Pathology . Boca Raton, FL, CRC Press, 1995, pp 1-24.
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
“The link between the intestinal microbiota and autism is supported by the following observations: 1) disease onset often follows antimicrobial therapy, 2) gastrointestinal abnormalities are often present at the onset of autism and frequently persist, and 3) autistic symptoms have sometimes been reduced by oral vancomy…”
BackgroundThe gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149
Dysbiosis and the immune system
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.7 · Cited by 1,769
Metadata
- Authors
- Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M.
- Affiliations
- Rush University Medical Center (US)
- University of California, Los Angeles (US)
- Sections of Pediatric Gastroenterology and Nutrition
- Rush Children's Hospital (US)
- Corresponding author
- Sandler, Richard H.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2000-07
- Volume
- 15
- Issue
- 7
- Pages
- 429-435
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W2020523926
- Cited by
- 614
- References
- 42
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 24 · 2023: 38 · 2022: 40 · 2021: 50 · 2020: 47 · 2019: 45 · 2018: 43 · 2017: 25 · 2016: 34 · 2015: 36 · 2014: 25 · 2013: 29 · 2012: 26
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Child Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer Pharmaceuticals
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- oral vancomycin, gut microbiota, antibiotic exposure, chronic diarrhea, gut-brain axis, autism treatment, behavioral interventions
- MeSH terms
- Administration, Oral, Autistic Disorder, Bacteria, Child, Child, Preschool, Dose-Response Relationship, Drug, Drug Administration Schedule, Feces, Female, Humans, Intestinal Mucosa, Male, Neuropsychological Tests, Regression, Psychology, Vancomycin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism. https://app.cochat.ai/papers/10.1177/088307380001500701
- The paper
- Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000). Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism. Journal of Child Neurology. https://doi.org/10.1177/088307380001500701
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.